Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

328.45 -1.62 (-0.49%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Nasdaq Futures Climb As Meta, Amazon Gains Offset Apple Slide: Analyst Points to 2 Factors Reinforcing Bullish Outlook This Year
Stock futures are pointing upwards on Friday as traders assess earnings reports from Meta Platforms, Inc. 
Via Benzinga
Cigna Outperforms In Q4 2023: Reports $51.1 Billion Revenue And $6.79 EPS
The Cigna Group reported an adjusted EPS of $6.79 and total revenues of $51.1 billion for the fourth quarter of 2023. 
Via Talk Markets
Earnings Scheduled For February 2, 2024
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion. 
Via Benzinga
Assessing Cigna Group: Insights From 8 Financial Analysts
Via Benzinga
Earnings Preview For Cigna Group
Via Benzinga
How Is The Market Feeling About Cigna Group?
Via Benzinga
$100 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today
Via Benzinga
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Paying Too Much for Insurance? Nationwide PPO Health Insurance Can Help
Via GetFeatured
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market
Aging is an inevitability, as much as we try to deny it. Under this context, these AgeTech stocks may prove quite relevant. 
Via InvestorPlace
Scott Integrated Pain Management Offers Innovative Ketamine Treatment for Complex Regional Pain Syndrome (CRPS)
Scott Integrated Pain Management is a renowned healthcare facility specializing in chronic pain management. They offer innovative treatments, personalized care, and a compassionate approach to... 
Via Newsworthy
Fortune 100 Giant Tyson Foods Breaks Ties With CVS Caremark, Marks Shift Towards Transparent Pharmacy Benefit Managers
Tyson Foods shifts from CVS Caremark to startup Rightway, targeting a 15% reduction in pharmacy costs. Explore Tyson's move and its impact on the pharmacy benefits landscape. 
Via Benzinga
Affordable Care Act Enrollment Highest Since Inception: Obamacare Enrollment Witnesses 31% Jump in 2024
Historic milestone in healthcare: 21.3M Americans enroll in Obamacare, a 31% increase from last year. Act now, open enrollment persists in select states until January 31. 
Via Benzinga
Cigna Group Unusual Options Activity For January 10
Via Benzinga
Prioritize Your Mental Health in 2024 With These 9 Tips
Via StatePoint Media
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 15 Years
Via Benzinga
Humana Blames Medicare Advantage As Stock Falls After Larger Than Expected Quarterly Loss, Grim Outlook
Humana faces challenges as Q4 2023 earnings disappoint. Adjusted EPS loss at $(0.11), revenue at $25.73 billion. 
Via Benzinga
5 top healthcare stocks for earnings growth in 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
Via MarketBeat
Humana Dives On Huge 2024 Earnings Warning
The health insurer says earnings will be barely half of estimates. 
Via Investor's Business Daily
TMS Therapy Offers Hope for Patients with Major Depressive Disorder in Abilene, TX
Abilene Brain Center introduces a cutting-edge treatment for Major Depressive Disorder (MDD) with NeuroStar TMS Therapy. This non-invasive procedure, utilizing Transcranial Magnetic Stimulation (TMS),... 
Via Newsworthy
A Closer Look at 7 Analyst Recommendations For Cigna Group
Via Benzinga
Affordable Care Act North Dakota: Every Health Group Unlocking Healthcare Horizons in the Region
Via GetFeatured
Medicare Patients Alert! Biden Administration Finalizes Rule to Streamline Health Insurance Prior Authorization
Biden Administration's rule for health information exchange and prior authorization processes in government-backed insurance plans. Streamlined procedures, reduced wait times, and estimated $15 billion... 
Via Benzinga
Humana Stock Falls Ill On This Warning; UNH, CVS Catch Virus
Humana slashed its Q4 earnings outlook on higher medical costs and warned about weak Medicare Advantage enrollment. 
Via Investor's Business Daily
Mental Health and Disability Advocates Services, which Gives Comprehensive Evaluation
Via Get News
UnitedHealth Earnings Due; Will UNH Stock Finally Leave The Waiting Room?
This IBD Long Term Leader keeps putting up good numbers. 
Via Investor's Business Daily
Wall Street's Top 10 Stock Calls This Week - Saturday, Jan. 6
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Jan. 2-5. 
Via Talk Markets
Health Exchange Agency (HEA) Celebrates Over a Decade of Empowering Seniors in Health Insurance Choices
Via Get News
Cigna's Medicare Business Sale: Health Care Service Could Scoop The Business
Cigna Group (NYSE: CI) is reportedly in advanced negotiations to divest its Medicare Advantage division and is presently in discussions to sell it to Health Care Service Corp Inc (NASDAQ: HCSG) for... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.